Evidence map›Paper›PMID 42318305›Full record

ArticleOpen forum infectious diseases2026

Association of Diabetes Mellitus With a Shared Hyperinflammatory Immune Response in Patients With Melioidosis and Patients With Tuberculosis: An Observational Case-Control Study.

Patpong Rongkard, Barbara Kronsteiner, Clare Eckold, Parinya Chamnan, Suchintana Chumseng, Mohammad Ali, Jennifer Hill, Priyanka Abraham, Emanuele Marchi, Direk Limmathurotsakul and 7 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Patpong RongkardNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-4094-5143
Barbara KronsteinerNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-0867-2867
Clare EckoldTuberculosis Centre and Department of Infection and Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0009-0001-2503-6021
Parinya ChamnanCardiometabolic Research Group, Department of Social Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand.ORCID https://orcid.org/0000-0002-5202-4149
Suchintana ChumsengMahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Mohammad AliNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-0170-7182
Jennifer HillNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-6205-7764
Priyanka AbrahamNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-5296-4499
Emanuele MarchiPeter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-1741-9353
Direk LimmathurotsakulMahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.ORCID https://orcid.org/0000-0001-7240-5320
Narisara ChantratitaDepartment of Microbiology, Mahidol University, Bangkok, Thailand.
T Eoin WestDivision of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-5503-7204
Sina A GharibDivision of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-2480-4367
Jacqueline M CliffTuberculosis Centre and Department of Infection and Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Nicholas P J DayNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-2309-1171
Paul KlenermanPeter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0003-4307-9161
Susanna J DunachieNDM Centre for Global Health Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-5665-6293

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

Background: Melioidosis is a serious infection caused by the bacterium Methods: Eighty-one patients with acute melioidosis from Northeast Thailand and 151 patients with tuberculosis from South Africa, Indonesia, Romania, and Peru, along with uninfected control cohorts, were studied by whole-blood RNA sequencing. Both supervised and unsupervised data analysis approaches, were performed including differential gene expression, pathway, and weighted gene coexpression network analyses. Results: DM status was associated with a hyperinflammatory response to both melioidosis and tuberculosis, with increased neutrophil and platelet degranulation and exaggerated activation of coagulation and scavenger activation pathways, along with decreased phosphoinositide 3-kinase protein kinase B signaling. In melioidosis, changes with DM were subtle but also included increased tumor necrosis factor signaling via nuclear factor κB and enhancement of endoplasmic reticulum stress and unfolded protein responses. DM-related changes were more distinct in tuberculosis, with marked reduction of interferon signaling responses. Conclusions: DM is associated with enhanced nonspecific inflammatory responses in both melioidosis and tuberculosis and an impaired interferon-mediated response to tuberculosis, with implications for future host-directed therapies.

Indexed as

diabetes mellitushost-pathogen responsemelioidosistranscriptometuberculosis

Identifiers

PMID42318305
PMCPMC13274303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.